Home › Trial NCT06122610
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
- Trial IDNCT06122610
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Wisconsin, Madison
- Enrollment4
- Start date2025-03-07
- ConditionsNeuroendocrine Tumors · Somatostatin Receptor-positive Neuroendocrine Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.